BAROSTIM® Hope for Heart Failure Study (HOPE4HF)
Barostim HOPE4HF Study
Sponsor: CVRx, Inc.
Listed as NCT01720160, this NA trial focuses on Heart Failure and remains ongoing. Sponsored by CVRx, Inc., it has been updated 13 times since 2012, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Apr 2022 — Jul 2024 [monthly]
Unknown Status NA
-
Oct 2021 — Apr 2022 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 8 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CVRx, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .